ATE254173T1 - P75 tnf-rezeptor-promotoren - Google Patents

P75 tnf-rezeptor-promotoren

Info

Publication number
ATE254173T1
ATE254173T1 AT95919786T AT95919786T ATE254173T1 AT E254173 T1 ATE254173 T1 AT E254173T1 AT 95919786 T AT95919786 T AT 95919786T AT 95919786 T AT95919786 T AT 95919786T AT E254173 T1 ATE254173 T1 AT E254173T1
Authority
AT
Austria
Prior art keywords
promotors
tnf receptor
sequence
upstream
preparation
Prior art date
Application number
AT95919786T
Other languages
English (en)
Inventor
David Wallach
Peter Kuhnert
Gotz Ehrhardt
Oliver Kemper
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE254173T1 publication Critical patent/ATE254173T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Input Circuits Of Receivers And Coupling Of Receivers And Audio Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
AT95919786T 1994-05-11 1995-05-11 P75 tnf-rezeptor-promotoren ATE254173T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL10963394A IL109633A (en) 1994-05-11 1994-05-11 Tnf receptor promoter
PCT/US1995/005853 WO1995031206A1 (en) 1994-05-11 1995-05-11 P75 tnf receptor promoters

Publications (1)

Publication Number Publication Date
ATE254173T1 true ATE254173T1 (de) 2003-11-15

Family

ID=11066126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95919786T ATE254173T1 (de) 1994-05-11 1995-05-11 P75 tnf-rezeptor-promotoren

Country Status (13)

Country Link
EP (1) EP0759759B1 (de)
JP (1) JP3663211B2 (de)
AT (1) ATE254173T1 (de)
AU (1) AU699280B2 (de)
CA (1) CA2189984C (de)
CY (1) CY2524B1 (de)
DE (1) DE69532115T2 (de)
DK (1) DK0759759T3 (de)
ES (1) ES2206505T3 (de)
IL (1) IL109633A (de)
PT (1) PT759759E (de)
WO (1) WO1995031206A1 (de)
ZA (1) ZA953841B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6287558B1 (en) 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
IL132105A0 (en) * 1998-12-24 2001-03-19 Yeda Res & Dev Caspase-8 interacting proteins
EP2583678A3 (de) 2004-06-24 2013-11-13 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner Moleküle und Assays für deren Nachweis
RS58911B1 (sr) 2011-11-01 2019-08-30 Resverlogix Corp Oralne formulacije sa trenutnim otpuštanjem za supstituisane hinazolinone
JP6292451B2 (ja) * 2012-09-20 2018-03-14 東亞合成株式会社 1型tnf受容体と2型tnf受容体の存在バランスを調節する合成ペプチド及びその利用

Also Published As

Publication number Publication date
WO1995031206A1 (en) 1995-11-23
ES2206505T3 (es) 2004-05-16
CA2189984A1 (en) 1995-11-23
EP0759759A1 (de) 1997-03-05
CA2189984C (en) 2008-03-25
DE69532115T2 (de) 2004-08-26
AU699280B2 (en) 1998-11-26
EP0759759A4 (de) 1997-11-26
JP3663211B2 (ja) 2005-06-22
JPH10500304A (ja) 1998-01-13
IL109633A (en) 2005-05-17
IL109633A0 (en) 1994-08-26
DE69532115D1 (de) 2003-12-18
EP0759759B1 (de) 2003-11-12
ZA953841B (en) 1996-01-17
PT759759E (pt) 2004-01-30
DK0759759T3 (da) 2004-02-02
CY2524B1 (en) 2006-02-08
AU2546895A (en) 1995-12-05

Similar Documents

Publication Publication Date Title
WO1992013950A3 (fr) SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
NO951138L (no) Mikropartikkelpreparater fremstilt fra biologisk nedbrytbare blandingspolymerer
EP0675225A3 (de) Weiches einlagiges Seidenpapier mit sehr niedriger Oberseite/Unterseite-Asymetrie.
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
CY2524B1 (en) P75 tnf receptor promoters
BG103169A (en) Ligand related to tumour necrotic factor
WO1994005791A3 (en) Dorsal tissue affecting factor and compositions
ZA97559B (en) Dihalopropene compounds, their use and intermediates for their production.
ITMI913465A1 (it) Procedimento per la depurazione dell'1, 1, 1-trifluoro-2-fluoroetano
WO1997012963A3 (en) A paf-acetylhydrolase and use in therapy
AU1769497A (en) Modified cytokines for therapeutic use
ZA966489B (en) New protein human MP52 Arg.
ZA969645B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.
ZA200202823B (en) Self-cleaving RNA sequences and their use for the control of protein synthesis.
ITTO920958A0 (it) Doccia per uso terapeutico.
CA2038030A1 (en) Synthetic peptides which contain sequences from factor viia, and the use thereof
FR2715821B1 (fr) Dispositif d'aide à la rééducation fonctionnelle, notamment du rachis.
FR2717073B1 (fr) Bac à shampoing pour malades allongés, notamment pour grabataires.
ITTO920656A1 (it) Sedia per operativita' chirurgica.
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
IT1284498B1 (it) Ago adatto per la terapia sclerosante delle varici.
IT1268116B1 (it) Sedia.
RU95111889A (ru) Способ местной анестезии в отиатрии

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0759759

Country of ref document: EP

REN Ceased due to non-payment of the annual fee